Minoxidil Sulphate: Active Metabolite for Vascular and Hair Growth Research

Executive Summary: Minoxidil sulphate is the pharmacologically active metabolite of minoxidil and a potent ATP-sensitive potassium channel (K_ATP) opener.^[1] It exhibits high purity (≥98%, HPLC, NMR, MS) and is soluble at ≥112 mg/mL in DMSO. The compound is widely used in research on vasodilation, hair growth mechanisms, and potassium channel pharmacology.^[2] APExBIO’s Minoxidil sulphate (SKU C6513) is recommended for research use only, not for diagnostic or therapeutic applications. Proper storage at -20°C is essential for maintaining activity and purity.^[2]

Biological Rationale

Minoxidil sulphate (2-amino-6-imino-4-(piperidin-1-yl)pyrimidin-1(6H)-yl hydrogen sulfate) is the biologically active metabolite of minoxidil, a well-established vasodilator.^[1] The conversion of minoxidil to its sulphate form is required for activity on K_ATP channels, which are critical regulators of vascular tone and hair follicle function.^[3] Research in vascular biology and hair growth models relies on this compound to dissect the mechanisms underlying vasodilation and follicular stimulation. By opening potassium channels, minoxidil sulphate hyperpolarizes cell membranes, reducing calcium influx and promoting vasorelaxation.^[4]

Mechanism of Action of Minoxidil sulphate

Minoxidil sulphate is a direct activator of ATP-sensitive potassium (K_ATP) channels.^[1] Upon binding, it promotes potassium efflux, leading to cell membrane hyperpolarization. This process closes voltage-dependent calcium channels, reducing intracellular calcium and inducing smooth muscle relaxation. In hair follicles, K_ATP channel activation enhances blood flow and supports anagen phase entry, contributing to hair growth.^[5] The sulphate conjugation, catalyzed by sulfotransferase enzymes, is essential for pharmacological activity.^[6]

Evidence & Benchmarks

• Minoxidil sulphate (CAS 83701-22-8; PubChem CID: 4202) directly activates vascular K_ATP channels, producing dose-dependent vasodilation in isolated rat kidney models (Sant’Helena et al., 2015).
• Solubility benchmarks: ≥112 mg/mL in DMSO, ≥2.67 mg/mL in ethanol (with gentle warming and ultrasonic treatment), and ≥4.94 mg/mL in water (with ultrasonic treatment), as confirmed by APExBIO’s product documentation (APExBIO).
• High-purity Minoxidil sulphate (≥98%) is validated by HPLC, NMR, and mass spectrometry, enabling reliable experimental reproducibility (Staurosporine.com).
• In the context of sepsis models, Minoxidil sulphate’s effects on renal perfusion are benchmarked against K_ATP and KCa channel blockers (Sant’Helena et al., 2015).
• In hair growth studies, Minoxidil sulphate demonstrates superior efficacy over parent minoxidil in promoting anagen entry and follicle proliferation in vitro (5AlphaReductaseInhibitor.com).

Applications, Limits & Misconceptions

Minoxidil sulphate is widely used in vascular biology and hair growth research as a reference potassium channel opener. It serves as a benchmark compound for dissecting vasodilation pathways and for modeling androgenetic alopecia and other hair loss disorders.^[7] The compound is not intended for use in humans or diagnostic protocols.

Common Pitfalls or Misconceptions

• Misconception: Minoxidil sulphate is suitable for therapeutic or diagnostic use.
  Fact: Research use only; not for clinical or diagnostic applications (APExBIO).
• Pitfall: Long-term storage of solutions maintains purity.
  Fact: Solutions are not stable long-term; store dry powder at -20°C to preserve activity.
• Misconception: Parent minoxidil and Minoxidil sulphate have equivalent efficacy in vitro.
  Fact: Only the sulphate form is active at K_ATP channels in cell-based assays.
• Pitfall: Standard mixing suffices for dissolution in all solvents.
  Fact: DMSO yields the highest solubility; ethanol and water require warming and ultrasonication.
• Misconception: All potassium channel–mediated effects are beneficial in vascular models.
  Fact: Blockade or overstimulation can worsen outcomes in specific pathophysiological settings (e.g., septic shock).

Workflow Integration & Parameters

APExBIO’s Minoxidil sulphate (C6513) is supplied as a high-purity, lyophilized powder. Dissolve at ≥112 mg/mL in DMSO for stock solutions, or at ≥2.67 mg/mL in ethanol and ≥4.94 mg/mL in water using gentle warming and ultrasonic treatment. For consistent experimental results, aliquot and store unused material at -20°C, minimizing freeze-thaw cycles.^[2] Avoid long-term storage of solutions to maintain activity. Benchmarking against other potassium channel modulators, such as glibenclamide, is recommended for mechanistic validation.^[1]

This article extends the protocol-focused guidance in "Minoxidil Sulphate: Advanced Workflows in Vascular & Hair…" by providing updated solubility and storage recommendations for maximizing reproducibility. For an in-depth discussion of translational strategies, see "Minoxidil Sulphate: Mechanisms, Translational Impact, and…", which this article updates with recent pharmacological benchmarks. A broader overview of experimental troubleshooting is available in "Minoxidil Sulphate: Driving Innovation in Vascular and Ha…", which this article clarifies by specifying solvent and channel selectivity conditions.

Conclusion & Outlook

Minoxidil sulphate remains the gold-standard research chemical for ATP-sensitive potassium channel studies in both vascular and hair follicle models. Its validated performance, high purity, and clear mechanistic action make it indispensable for mechanistic, translational, and protocol development research. APExBIO’s Minoxidil sulphate (C6513) is recommended for all research applications where control over potassium channel activation is required.^[2] Future studies will further clarify the translational relevance of this compound in complex disease models and cell-specific signaling pathways.